176 related articles for article (PubMed ID: 35949347)
1. Management of a rare ovarian carcinosarcoma: A case report and literature review.
Fu J
Exp Ther Med; 2022 Sep; 24(3):583. PubMed ID: 35949347
[TBL] [Abstract][Full Text] [Related]
2. A rare case of ovarian carcinosarcoma with squamous cell carcinoma.
Daimon A; Fujiwara S; Tanaka Y; Tanaka T; Ohmichi M
J Ovarian Res; 2019 Apr; 12(1):32. PubMed ID: 30947745
[TBL] [Abstract][Full Text] [Related]
3. Genetic Analysis and Combined Therapy of Surgery and Chemotherapy for the Progression-Free Survival of a Patient with Ovarian Carcinosarcoma: A Case Report and Literature Review.
Guo S; Zhang X; Tang Q; Zhou M; Jiang D; Yu E
Onco Targets Ther; 2022; 15():717-725. PubMed ID: 35791423
[TBL] [Abstract][Full Text] [Related]
4. [A case and literature review of ovarian carcinosarcoma with long-term survival after repeated recurrences].
Asano M; Hasegawa K; Tsukada K; Tada S; Mizoguchi Y; Imaeda Y; Ikeda M; Kawamura K; Fujii T
Gan To Kagaku Ryoho; 2014 Aug; 41(8):1031-6. PubMed ID: 25132040
[TBL] [Abstract][Full Text] [Related]
5. Primary peritoneal carcinosarcoma arising from the Douglas pouch: A case report.
Koyanagi T; To Y; Ando M; Matsuoka S; Nakamura S; Goto M; Kondo H; Eguchi F; Tsujioka H
Mol Clin Oncol; 2018 Nov; 9(5):485-488. PubMed ID: 30345041
[TBL] [Abstract][Full Text] [Related]
6. Carcinosarcoma arising from high-grade serous carcinoma of the ovary without estrogen receptor, WT-1, and PAX8 immunoreactivity.
Harada N; Nobuhara I; Haruta N; Higashiura Y; Fujii H; Yamao K; Shimada K
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):110-114. PubMed ID: 35181017
[TBL] [Abstract][Full Text] [Related]
7. Case Report: Niraparib as Maintenance Therapy in A Patient With Ovarian Carcinosarcoma.
Zhang JQ; Zhao BB; Wang MM; Li L
Front Oncol; 2021; 11():603591. PubMed ID: 34938651
[TBL] [Abstract][Full Text] [Related]
8. Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.
Yalcin I; Meydanli MM; Turan AT; Taskin S; Sari ME; Gungor T; Akbayir O; Ayhan A
Int J Clin Oncol; 2018 Apr; 23(2):329-337. PubMed ID: 29143144
[TBL] [Abstract][Full Text] [Related]
9. Long-term recurrence-free survival of a patient with advanced pure primary ovarian squamous cell carcinoma treated with dose-dense paclitaxel combined with carboplatin.
Yazawa H; Hiraiwa T; Ito F; Fujimori K
Obstet Gynecol Sci; 2017 Nov; 60(6):587-592. PubMed ID: 29184868
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
[TBL] [Abstract][Full Text] [Related]
11. Carcinosarcoma of the uterus: A case report.
Adachi Y; Nonogaki H; Minamiguchi S; Li M; Ikehara S
Mol Clin Oncol; 2016 Apr; 4(4):571-573. PubMed ID: 27073665
[TBL] [Abstract][Full Text] [Related]
12. Comparing Paclitaxel-Carboplatin with Paclitaxel-Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer.
Huang CY; Cheng M; Lee NR; Huang HY; Lee WL; Chang WH; Wang PH
Int J Environ Res Public Health; 2020 Mar; 17(7):. PubMed ID: 32224896
[TBL] [Abstract][Full Text] [Related]
13. Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report.
Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Tangtiang K; Piyawang W; Bhamarapravatana K
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S121-5. PubMed ID: 26387399
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma.
Kuhn W; Rutke S; Späthe K; Schmalfeldt B; Florack G; von Hundelshausen B; Pachyn D; Ulm K; Graeff H
Cancer; 2001 Nov; 92(10):2585-91. PubMed ID: 11745193
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic Resection of a High Grade Serous Ovarian Cancer that Recurred at the Vaginal Stump with Extensive Pelvic Adhesions after Complete Surgical Staging.
Li J; Duan J; Mao R; Jiang W
J Minim Invasive Gynecol; 2022 Mar; 29(3):343-344. PubMed ID: 34871772
[TBL] [Abstract][Full Text] [Related]
16. "Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities".
Rauh-Hain JA; Birrer M; Del Carmen MG
Gynecol Oncol; 2016 Aug; 142(2):248-54. PubMed ID: 27321238
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Carcinosarcoma of the Fallopian Tube Mimicking Ovarian Cancer: A Case Report and Genetic Analysis.
Kim SW; Kim Y
J Nippon Med Sch; 2021; 88(6):574-578. PubMed ID: 34980744
[TBL] [Abstract][Full Text] [Related]
18. Carcinosarcoma of the ovary: a review of the literature.
del Carmen MG; Birrer M; Schorge JO
Gynecol Oncol; 2012 Apr; 125(1):271-7. PubMed ID: 22155675
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging for the diagnosis of malignant mixed Mullerian tumor of ovary: Two case reports.
Jin X; Zhu P; Fan S; Dai J
Medicine (Baltimore); 2023 Dec; 102(50):e36569. PubMed ID: 38115369
[TBL] [Abstract][Full Text] [Related]
20. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Shi T; Zhu J; Feng Y; Tu D; Zhang Y; Zhang P; Jia H; Huang X; Cai Y; Yin S; Jiang R; Tian W; Gao W; Liu J; Yang H; Cheng X; Zang R
Lancet Oncol; 2021 Apr; 22(4):439-449. PubMed ID: 33705695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]